Modulation of autoimmune diseases by iPS cells

Fengyang Lei, Rizwanul Haque, Xiaofang Xiong, Jianxun Song

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Autoimmune disease is typically caused by the activated self-reacted immune cells. The mainstream treatment to autoimmune disorders is composed of different mechanisms of immunosuppression. In recent years, a new subtype of T cells called regulatory T (Treg) cells have been identifi ed to maintain the immune homeostasis in terms of suppressing the activated immune components. According to this discovery, it is suggested that treating autoimmune patients by supplementing Treg cells would be a good choice. However, due to their natural scarcity, it is diffi cult to isolate a desired number of Treg for this therapeutical approach. Here, we report that by using stem cells, especially the induced pluripotent stem (iPS) cells, we are able to generate a signifi cant amount of Treg cells for the autoimmune prevention and treatment.

Original languageEnglish (US)
Pages (from-to)365-377
Number of pages13
JournalMethods in Molecular Biology
StatePublished - 2014

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics


Dive into the research topics of 'Modulation of autoimmune diseases by iPS cells'. Together they form a unique fingerprint.

Cite this